SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-14-001148
Filing Date
2014-04-04
Accepted
2014-04-04 17:13:52
Documents
7
Period of Report
2014-05-20
Effectiveness Date
2014-04-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT geron_def14a.htm DEF 14A 908668
2 GRAPHIC geron_def14a1x1x1.jpg GRAPHIC 4924
3 GRAPHIC geron_def14a1x1x2.jpg GRAPHIC 8764
4 GRAPHIC geron_def14a1x2x1.jpg GRAPHIC 7945
5 GRAPHIC geron_def14a6x3x1.jpg GRAPHIC 8768
6 GRAPHIC geron_def14ax7x1.jpg GRAPHIC 13651
7 GRAPHIC geronx2x1.jpg GRAPHIC 4233
  Complete submission text file 0001206774-14-001148.txt   977269
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 14746774
SIC: 2834 Pharmaceutical Preparations